NTLA icon

Intellia Therapeutics

291 hedge funds and large institutions have $2.68B invested in Intellia Therapeutics in 2023 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 122 increasing their positions, 77 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more ownership

Funds ownership:

more capital invested

Capital invested by funds: $ → $

3% more funds holding

Funds holding: 283291 (+8)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

30% less call options, than puts

Call options by funds: $21.1M | Put options by funds: $30.2M

Holders
291
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$21.1M
Puts
$30.2M
Net Calls
Net Calls Change

Top Buyers

1 +$61M
2 +$44.6M
3 +$30.6M
4
Marshall Wace
Marshall Wace
United Kingdom
+$27.2M
5
BlackRock
BlackRock
New York
+$26.8M

Top Sellers

1 -$21.7M
2 -$9.34M
3 -$8.73M
4
Millennium Management
Millennium Management
New York
-$7.37M
5
Norges Bank
Norges Bank
Norway
-$6.59M
Name Holding Trade Value Shares
Change
Change in
Stake
151
$512K
152
$505K
153
$502K
154
$497K
155
$475K
156
$448K
157
$439K
158
$424K
159
$408K
160
$403K
161
$389K
162
$385K
163
$376K
164
$372K
165
$370K
166
$361K
167
$360K
168
$358K
169
$357K
170
$350K
171
$345K
172
$326K
173
$322K
174
$319K
175
$318K